1 – 9 of 9
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
(
- Contribution to journal › Article
- 2011
-
Mark
Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3
(
- Contribution to journal › Article
-
Mark
Genome-wide association study identifies three new melanoma susceptibility loci
(
- Contribution to journal › Article
- 2009
-
Mark
Selection criteria for genetic assessment of patients with familial melanoma
(
- Contribution to journal › Scientific review
-
Mark
Genome-wide association study identifies three loci associated with melanoma risk
(
- Contribution to journal › Article
- 2008
-
Mark
Common sequence variants on 20q11.22 confer melanoma susceptibility
(
- Contribution to journal › Article
- 2007
-
Mark
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents
(
- Contribution to journal › Article
- 2006
-
Mark
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
(
- Contribution to journal › Article
- 2002
-
Mark
Genetic testing for melanoma
(
- Contribution to journal › Article